Gilead Sciences (GILD) PT Raised to $154 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Tim Anderson raised the price target on Gilead Sciences (NASDAQ: GILD) to $154.00 (from $144.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
